Cargando…

The Experience Sampling Method—Evaluation of treatment effect of escitalopram in IBS with comorbid panic disorder

BACKGROUND: Confirming treatment response in clinical trials for irritable bowel syndrome (IBS) is challenging, due to the lack of biomarkers and limitations of the currently available symptom assessment tools. The Experience Sampling Method (ESM) might overcome these limitations by collecting digit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vork, Lisa, Mujagic, Zlatan, Drukker, Marjan, Keszthelyi, Daniel, Conchillo, José M., Hesselink, Martine A. M., van Os, Jim, Masclee, Ad A. M., Leue, Carsten, Kruimel, Joanna W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379179/ https://www.ncbi.nlm.nih.gov/pubmed/30460734 http://dx.doi.org/10.1111/nmo.13515

Ejemplares similares

Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome
por: Weerts, Zsa Zsa R. M., et al.
Publicado: (2019)

Patient-Specific Stress–Abdominal Pain Interaction in Irritable Bowel Syndrome: An Exploratory Experience Sampling Method Study
por: Vork, Lisa, et al.
Publicado: (2020)

Examining the optimal cutoff values of HADS, PHQ‐9 and GAD‐7 as screening instruments for depression and anxiety in irritable bowel syndrome
por: Snijkers, Johanna T. W., et al.
Publicado: (2021)

Age-Related Decrease in Abdominal Pain and Associated Structural- and Functional Mechanisms: An Exploratory Study in Healthy Individuals and Irritable Bowel Syndrome Patients
por: Beckers, Abraham B., et al.
Publicado: (2021)

Using a Patient Hotel: Perceptions of the Quality of Care by Patients Undergoing Analysis for Gastrointestinal Motility Disorders in the Netherlands
por: Masclee, Gwen MC, et al.
Publicado: (2022)

Gastric peroral endoscopic pyloromyotomy for decompensated gastroparesis: comprehensive motility analysis in relation to treatment outcomes
por: Conchillo, José M., et al.
Publicado: (2021)

Psychometric evaluation of an experience sampling method–based patient‐reported outcome measure in functional dyspepsia
por: Klaassen, Tim, et al.
Publicado: (2021)

Antroduodenal motility recording identifies characteristic patterns in gastroparesis related to underlying etiology
por: Hereijgers, Maartje J. M., et al.
Publicado: (2022)

Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study
por: Keszthelyi, Daniel, et al.
Publicado: (2012)

Therapeutic strategies in gastroparesis: Results of stepwise approach with diet and prokinetics, Gastric Rest, and PEG‐J: A retrospective analysis
por: Strijbos, Denise, et al.
Publicado: (2019)

Measurement of Esophagogastric Junction Distensibility May Assist in Selecting Patients for Endoluminal Gastroesophageal Reflux Disease Surgery: Author’s Reply
por: Smeets, Fabiënne G M, et al.
Publicado: (2015)

The therapeutic potential of escitalopram in the treatment of panic disorder
por: Townsend, Mark H, et al.
Publicado: (2007)

Does Measurement of Esophagogastric Junction Distensibility by EndoFLIP Predict Therapy-responsiveness to Endoluminal Fundoplication in Patients With Gastroesophageal Reflux Disease?
por: Smeets, Fabiënne G M, et al.
Publicado: (2015)

Real-time Symptom Assessment in Patients With Endometriosis: Psychometric Evaluation of an Electronic Patient-Reported Outcome Measure, Based on the Experience Sampling Method
por: van Barneveld, Esther, et al.
Publicado: (2023)

Colonoscopy is safe and not associated with higher pain scores in patients with hypermobility spectrum disorder: results from an exploratory prospective study
por: Beckers, Abraham B., et al.
Publicado: (2020)

Integrated fecal microbiome–metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome
por: Mujagic, Zlatan, et al.
Publicado: (2022)

The Intestinal Barrier in Irritable Bowel Syndrome: Subtype-Specific Effects of the Systemic Compartment in an In Vitro Model
por: Ludidi, Samefko, et al.
Publicado: (2015)

Exploration of the Esophageal Mucosal Barrier in Non-Erosive Reflux Disease
por: Rinsma, Nicolaas F., et al.
Publicado: (2017)

The estimation of a preference-based single index for the IBS-QoL by mapping to the EQ-5D-5L in patients with irritable bowel syndrome
por: Sturkenboom, Rosel, et al.
Publicado: (2021)

Digital Instruments for Reporting of Gastrointestinal Symptoms in Clinical Trials: Comparison of End-of-Day Diaries Versus the Experience Sampling Method
por: Beckers, Abraham B, et al.
Publicado: (2021)

Intestinal barrier function is maintained with aging – a comprehensive study in healthy subjects and irritable bowel syndrome patients
por: Wilms, Ellen, et al.
Publicado: (2020)

Blunted autonomic reactivity to pharmacological panic challenge under long-term escitalopram treatment in healthy men
por: Agorastos, Agorastos, et al.
Publicado: (2015)

Pilot study of genome-wide DNA methylation and gene expression for treatment response to escitalopram in panic disorder
por: Zou, Zhi-Li, et al.
Publicado: (2023)

Sensory Adaptation Training or Escitalopram for IBS With Constipation and Rectal Hypersensitivity: A Randomized Controlled Trial
por: Rao, Satish S.C., et al.
Publicado: (2021)

Systematic Review: Contribution of the Gut Microbiome to the Volatile Metabolic Fingerprint of Colorectal Neoplasia
por: van Vorstenbosch, Robert, et al.
Publicado: (2022)

Diet Quality and Dietary Inflammatory Index in Dutch Inflammatory Bowel Disease and Irritable Bowel Syndrome Patients
por: de Graaf, Marlijne C. G., et al.
Publicado: (2022)

Patient preferences of healthcare delivery in irritable bowel syndrome: a focus group study
por: Masclee, Gwen M. C., et al.
Publicado: (2021)

Flexible Assertive Community Treatment, Severity of Symptoms and Psychiatric Health Service Use, a Real life Observational Study
por: Drukker, Marjan, et al.
Publicado: (2013)

An n=1 Clinical Network Analysis of Symptoms and Treatment in Psychosis
por: Bak, Maarten, et al.
Publicado: (2016)

Correction: An n=1 Clinical Network Analysis of Symptoms and Treatment in Psychosis
por: Bak, Maarten, et al.
Publicado: (2016)

Electrical Stimulation Therapy for Gastroesophageal Reflux Disease
por: Rinsma, Nicolaas F, et al.
Publicado: (2014)

Preschool Communication: Early Identification of Concerns About Preschool Language Development and Social Participation
por: Doove, Bernice M., et al.
Publicado: (2021)

Long-term Escitalopram Treatment in Korean Patients with Panic Disorder: A Prospective, Naturalistic, Open-label, Multicenter Trial
por: Choi, Kwan-Woo, et al.
Publicado: (2012)

Antipsychotic medications and cognitive functioning in bipolar disorder: moderating effects of COMT Val(108/158) Met genotype
por: Arts, Baer, et al.
Publicado: (2013)

Intraduodenal Administration of Intact Pea Protein Effectively Reduces Food Intake in Both Lean and Obese Male Subjects
por: Geraedts, Maartje C. P., et al.
Publicado: (2011)

Patient-Reported Outcome Measure for Real-time Symptom Assessment in Women With Endometriosis: Focus Group Study
por: van Barneveld, Esther, et al.
Publicado: (2021)

Do Patients’ and Physicians’ Perspectives Differ on Preferences for Irritable Bowel Syndrome Treatment?
por: Sturkenboom, Rosel, et al.
Publicado: (2022)

Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis
por: Bak, Maarten, et al.
Publicado: (2014)

Smart Data Collection for the Assessment of Treatment Effects in Irritable Bowel Syndrome: Observational Study
por: Weerts, Zsa Zsa R M, et al.
Publicado: (2020)

Correction: Smart Data Collection for the Assessment of Treatment Effects in Irritable Bowel Syndrome: Observational Study
por: Weerts, Zsa Zsa R M, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2ku00gs1sj068k79afg9o5vjb4